Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abus Treat. 2005;28(4):321–9.
American Civil Liberties Union of New Mexico (ACLUNM), Drug Policy Alliance, New Mexico Voices for Children, and Young Women United. Racial and ethnic Bias in New Mexico drug law enforcement: a summary of preliminary findings and recommendations. Albuquerque: ACLUNM; 2017.
Amnesty International. “If you are poor you are killed”: extrajudicial executions in the Philippines’ ‘War on Drugs’. London: Amnesty International; 2017.
Anglin MD. The efficacy of civil commitment in treating narcotic addiction. In: Leukfield CG, Tims FM, editors. Compulsory treatment of drug abuse: research and clinical practice, NIDA research monograph 86. Rockville: National Institute on Drug Abuse; 1988.
Asmussen K, Brims L, McBride T. 10 steps for evaluation success. London: Early Intervention Foundation; 2019.
Barnard M, Webster S, O’Connor W, Jones A, Donmall M. The Drug Treatment Outcomes Research Study (DTORS): qualitative study. Home Office research 26. London: Home Office; 2009.
Bean P. Drugs and crime. 2nd ed. Cullompton: Willan Publishing; 2004.
Bell J. Medications in recovery: Re-orientating drug dependence treatment. Appendix C - Opioid substitution treatment and its effectiveness: review of the evidence. London: National Treatment Agency; 2012.
Bright DA, Martire KA. Does coerced treatment of substance-using offenders lead to improvements in substance use and recidivism? A review of thetreatment efficacy literature. Aust Psychol. 2012;48(1):69–81.
Bronson J, Stroop J, Zimmer S, Berzofsky M. Drug use, dependence, and abuse among state prisoners and jail inmates, 2007–2009. Virginia: U.S. Department of Justice; 2017.
Bull M. A comparative review of best practice guidelines for the diversion of drug related offenders. Int J Drug Policy. 2005;16(4):223–34.
Degenhardt L, Hallam C, Bewley-Taylor D. Comparing the drug situation across countries: Problems, pitfalls and possibilities. Briefing paper 19. Oxford: Beckley Foundation; 2009.
Dekker J, O’Brien K, Smith N. Evaluation of the compulsory drug treatment program (CDTP). Sydney: New South Wales Bureau of Crime Statistics and Research; 2010.
Department of Health. Drug misuse and dependence: UK guidelines on clinical management 2017. London: Department of Health; 2017.
Donmall M, Jones A, Davies L, Barnard M. Summary of key findings from the Drug Treatment Outcomes Research Study (DTORS). Research report 23. London: Home Office; 2009.
Drug Policy Alliance. The drug war, mass incarceration and race. New York: Drug Policy Alliance; 2018.
Eastwood N, Fox E, Rosmarin A. A quiet revolution: drug decriminalisation across the globe. London: Release; 2016.
European Monitoring Centre for Drugs and Drug Addiction EMCDDA. Guidelines for the treatment of drug dependence: a European perspective. Luxembourg: Publications Office of the European Union; 2011.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Alternatives to punishment for drug-using offenders. Luxembourg: Publications Office of the European Union; 2015.
European Monitoring Centre for Drugs and Drug Addition (EMCDDA). Estimating public expenditure on drug-law offenders in prison in Europe. Luxembourg: Publications Office of the European Union; 2014.
European Monitoring Centre for Drugs and Drug Addition (EMCDDA). Treatment for cocaine dependence: reviewing current evidence. Luxembourg: Publications Office of the European Union; 2014.
Fiorentine R, Nakashima J, Anglin MD. Client engagement with drug treatment. J Subst Abus Treat. 1999;17(3):199–206.
Friedmann PD, Taxman FS, Henderson CE. Evidence-based treatment practices for drug-involved adults in the criminal justice system. J Subst Abus Treat. 2007;32(3):267–77.
Girelli G. The death penalty for drug offences: global overview 2018. London: Harm Reduction International; 2019.
Gisev N, Bharat C, Larney S, Dobbins T, Weatherburn D, Hickman M, Farrell M, Degenhardt L. The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study. Lancet Public Health. 2019;4:e334–42.
Goldstein PJ. The drugs/violence nexus: a tripartite conceptual framework. J Drug Issues. 1985;15(4):493–506.
Gossop M, Marsden J, Stewart D, Kidd T. The national treatment outcome research study (NTORS): 4–5 year follow-up results. Addiction. 2003;98(3):291–303.
Gossop M, Trakada K, Stewart D, Witton J. Reductions in criminal convictions after addiction treatment: 5-year follow-up. Drug Alcohol Depend. 2005;79(3):295–302.
Harm Reduction International (HRI). Global state of harm reduction 2018. London: HRI; 2018.
Harper R, Hardy S. An evaluation of motivational interviewing as a method of intervention with clients in a probation setting. Br J Soc Work. 2000;30(3):393–400.
Hawken A, Kleiman M. Managing drug involved probationers with swift and certain sanctions: evaluating Hawaii’s HOPE. Washington, D.C.: National Institute of Justice; 2009.
Hayhurst KP, Leitner M, Davies L, Millar T, Jones A, Flentje R, Hickman M, Fazel S, Mayet S, King C, Senior J, Lennox C, Gold R, Buck D, Shaw J. The effectiveness of diversion programmes for offenders using class a drugs: a systematic review and meta-analysis. Drugs Educ Prev Policy. 2019;26(2):113–24.
HM Inspectorate of Prisons (HMIP). Changing patterns of substance misuse in adult prisons and service responses. London: HMIP; 2015.
Holloway K, Bennett T, Farrington DP. The effectiveness of criminal justice and treatment programmes in reducing drug-related crime: a systematic review. Online research report 26/05. London, UK: Home Office; 2005.
Hughes C, Seear K, Ritter A, Mazerolle L. Criminal justice responses relating to personal use and possession of illicit drugs: the reach of Australian drug diversion programs and barriers and facilitators to expansion. A report for the Commonwealth Department of Health. NDARC, UNSW: Sydney; 2018.
Hughes C, Seear K, Ritter A, Mazerolle L. Criminal justice responses relating to personal use and possession of illicit drugs: the reach of Australian drug diversion programs and barriers and facilitators to expansion, DPMP monograph no. 27. Sydney: UNSW; 2019.
Hughes C, Stevens A, Hulme S, Cassidy R. Review of approaches taken in Ireland and in other jurisdictions to simple possession drug offences. A report for the Irish Department of Justice and Equality and the Department of Health. UNSW Australia and University of Kent; 2018.
Inciardi JA, McBride DC. Reviewing the ‘TASC’ (treatment alternatives to street crime) experience. J Crime Justice. 1992;15(1):45–61.
Johnson SD, Tilley N, Bowers KJ. Introducing EMMIE: an evidence rating scale to encourage mixed-method crime prevention synthesis reviews. J Exp Criminol. 2015;11(3):459–73.
Jones A. The impact of and interaction between motivation and coercion for drug misuse treatment seekers in England. PhD thesis. Faculty of Medical and Human Sciences: University of Manchester; 2012.
Jones A, Weston S, Moody A, Millar T, Dollin L, Anderson T, Donmall M. The drug treatment outcomes research study (DTORS): baseline report. Research Report 3. London: Home Office; 2007.
Kilmer B, Nicosia N, Heaton P, Midgette G. Efficacy of frequent monitoring with swift, certain, and modest sanctions for violations: insights from South Dakota’s 24/7 Sobriety Project. Am J Public Health. 2013;103:e37–43.
Koehler JA, Humphreys DK, Akoensi TD, de Ribera OS, Lösel F. A systematic review and meta-analysis on the effects of European drug treatment programmes on reoffending. Psychol Crime Law. 2014;20(6):584–602.
Kruithof K, Davies M, Disley E, Strang S, Ito K. Study on alternatives to coercive sanctions as response to drug law offences and drug-related crimes. Brussels: European Commission; 2016.
Larney L, Peacock A, Leung J, Colledge S, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Global Health. 2017;5:e1208–20.
Marlowe DB. Depot naltrexone in lieu of incarceration: a behavioural analysis of coerced treatment for addicted offenders. J Subst Abus Treat. 2006;31(2):131–9.
McIntosh J, Bloor M, Robertson M. The effect of drug treatment upon the commission of acquisitive crime. J Subst Abus. 2007;12(5):375–84.
McSweeney T, Hughes CE, Ritter A. The impact of compliance with a compulsory model of drug diversion on treatment engagement and reoffending. Drugs Educ Prev Policy. 2018;25(1):56–66.
McSweeney T, Stevens A, Hunt N, Turnbull PJ. Twisting arms or a helping hand? Assessing the impact of “coerced” and comparable “voluntary” drug treatment options. Br J Criminol. 2007;47(3):470–90.
Millar T, Donmall M, Jones A. Treatment effectiveness: demonstration analysis of treatment surveillance data about treatment completion and retention. London: National Treatment Agency for Substance Misuse; 2004.
National Institute on Drug Abuse. Principles of drug abuse treatment for criminal justice populations: a research-based guide. Rockville: NIDA; 2006.
National Treatment Agency for Substance Misuse (NTASM). Estimating the crime reduction benefits of drug treatment and recovery. London: NTASM; 2012.
Pacula RL, Hoorens S, Kilmer B, Reuter PH, Burgdorf JR, Hunt P. Issues in estimating the economic cost of drug abuse in consuming nations. Cambridge: RAND Europe; 2009.
Patterson E, Sullivan T, Ticehurst A, Bricknell S. Drug use monitoring in Australia: 2015 and 2016 report on drug use among police detainees. Canberra: Australian Institute of Criminology; 2018.
Pawson R, Tilley N. Realistic evaluation. London: Sage; 1997.
Perry AE, Neilson M, Martyn-St James M, Glanville JM, Woodhouse R, Hewitt C. Interventions for female drug-using offenders. Cochrane Database Syst Rev. John Wiley & Sons; 2015:6. Art. No.: CD010910.
Perry AE, Neilson M, Martyn-St James M, Glanville JM, Woodhouse R, Godfrey C, Hewitt C. Pharmacological interventions for drug-using offenders. Cochrane Database of Systematic Reviews: John Wiley & Sons; 2015.
Prendergast ML, Podus D, Chang E, Urada D. The effectiveness of drug abuse treatment: a meta-analysis of comparison group studies. Drug Alcohol Depend. 2002;67(1):53–72.
Public Health England. An evidence review of the outcomes that can be expected of drug misuse treatment in England. London: PHE; 2017.
Schaub M, Stevens A, Berto D, Hunt N, Kerschl V, McSweeney T, Oeuvray K, Puppo I, Santa Maria A, Trinkl B, Werdenich W, Uchtenhagen A. Comparing outcomes of ‘voluntary’ and ‘quasi-compulsory’ treatment of substance dependence in Europe. Eur Addict Res. 2010;16(1):53–60.
Scottish Public Health Observatory (ScotPHO). Addiction prevalence testing for performance measurement purposes, 2018–19. Glasgow: ScotPHO; 2019.
Shanahan M, Hughes CE, McSweeney T, Griffin B. Alternate policing strategies: cost-effectiveness of cautioning for cannabis offences. Int J Drug Policy. 2017;41(1):140–7.
Shiner M, Carre Z, Delsol R, Eastwood N. The colour of injustice: ‘race’, drugs and law enforcement in England and Wales. London: StopWatch and Release; 2018.
Stevens A. The ethics and effectiveness of coerced treatment of people who use drugs. Human Rights Drugs. 2012;2(1):7–16.
Stevens A, Berto D, Heckmann W, Kerschl V, Oeuvray K, van Ooyen M, Steffan E, Uchtenhagen A. Quasi-compulsory treatment of drug dependent offenders: an international literature review. Subst Use Misuse. 2005;40(3):269–83.
Stevens A, Berto D, Frick U, Hunt N, Kerschl V, McSweeney T, Oeuvray K, Schaaf S, Trinkl B, Uchtenhagen A, Werdenich A. The relationship between legal status, perceived pressure and motivation in treatment for drug dependence: results from a European study of quasi-compulsory treatment. Eur Addict Res. https://doi.org/10.1007/s11229-010-9786-3. 2006;12(4):97–209.
Strang J, Groshkova T, Metrebian N. New heroin-assisted treatment: Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond, EMCDDA insights series. Luxembourg: Publications Office of the European Union; 2012.
Teesson M, Ross J, Darke S, Lynskey M, Ali R, Ritter A, et al. One-year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend. 2006;83(2):174–80.
The Sentencing Project. Trends in U.S. corrections. Washington, D.C.: The Sentencing Project; 2019.
Turnbull PJ, McSweeney T, Webster R, Edmunds M, Hough M. Drug treatment and testing orders: final evaluation report. Home Office Research Study no. 212. London: Home Office; 2000.
United Nations Commission on Crime Prevention and Criminal Justice. World crime trends and emerging issues and responses in the field of crime prevention and criminal justice. Vienna: United Nations; 2013.
United Nations Congress on Crime Prevention and Criminal Justice. State of crime and criminal justice worldwide. Vienna: United Nations; 2015.
United Nations Office on Drugs and Crime. Handbook of basic principles and promising practices on alternatives to imprisonment. Vienna: UNODC; 2007.
United Nations Office on Drugs and Crime (UNODC). World drug report 2019, booklet 2: global overview of drug demand and supply. Vienna: UNODC; 2019.
Vuong T, Ritter A, Hughes C, Shanahan M, Barrett L. Mandatory alcohol and drug treatment: what is it and does it work? Sydney: DPMP, UNSW; 2019.
Walmsley R. World prison population list. 12th ed. London: Institute for Criminal Policy Research; 2018.
Werb D, Kamarulzaman A, Meacham MC, Rafful C, Fischer B, Strathdee SA, Wood E. The effectiveness of compulsory drug treatment: a systematic review. Int J Drug Policy. 2016;28(1):1–9.